Stifel has upgraded Editas Medicine Inc (NASDAQ: EDIT), saying the company's sickle cell disease candidate, EDIT-301's progress, has received minimal credit from investors.
Shares of Brinker International, Inc. (NYSE: EAT) were rising in early trading on Friday.
The latest investor meetings with management highlighted progress with regarding Chili's turnaround efforts, according to Stifel.
Morgan Stanley analyst Manan Gosalia revised the rating for the midcap banks Valley National Bancorp (NASDAQ: VLY), Zions Bancorporation N.A. (NASDAQ: ZION), Commerc